NYSE:GMED

71.04
1.36 (1.95%) 1d
0
BUY

Being in the medical parts business, it is like Stryker but much smaller. It also has a software machine interface that helps the installation of these parts. Sales have grown about 12% annually over the past 5 years. Also it is an opportunity for Asian demographic tailwinds.

PAST TOP PICK
(A Top Pick Nov 08/21, Down 11%) They make surgical robots. Got hit during Covid with a lack of surgeries. Cash rich with $1 billion. Well-positioned now. Down the road, there are a take-out candidate.
TOP PICK
A health-teck. They have an interesting product called Excelcius GPS. It is a surgical robot for spinal surgeries. They integrated imaging into it: X-Ray and MRI. As we move forward elective surgeries will start to get booked again. (Analysts’ price target is $87.73)
PARTIAL BUY

He recommended it around 18 months ago, and it has doubled in price. Drawbacks before: had no international presence and not enough salespeople, but that has turned around, as reflected in the price jump. Earnings growing 10-15% annually. No debt, but pay no dividend. Buy half a position and watch, but don't buy heavily because it may
drop badly during a correction.

BUY ON WEAKNESS

Since he recommended this, it’s gone from $22 to $46. This is medical technology for spying related injuries. The stock price has taken off because the company has gotten their act together and has started to move outside of the US. Their sales teams are in place. A lot of their competitors have not been allocating capital towards the spine business. This company just came out with a new robotic invention that will help surgeons do all the spine surgeries. Earnings have jumped up nicely, and he is expecting anywhere from $143-$178 a share over the next couple of years, but we are still seeing the stock trading at roughly 32X earnings. Wait for a pullback or just buy half for the moment.

BUY

This is a tiny little $2 billion company that is in robotics of spinal care. Growing at a wonderful rate, but the street hasn’t adapted to them.

Showing 1 to 6 of 6 entries
  • «
  • 1
  • »

Globus Medical(GMED-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Globus Medical is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Globus Medical(GMED-N) Frequently Asked Questions

What is Globus Medical stock symbol?

Globus Medical is a American stock, trading under the symbol GMED-N on the New York Stock Exchange (GMED). It is usually referred to as NYSE:GMED or GMED-N

Is Globus Medical a buy or a sell?

In the last year, there was no coverage of Globus Medical published on Stockchase.

Is Globus Medical a good investment or a top pick?

Globus Medical was recommended as a Top Pick by on . Read the latest stock experts ratings for Globus Medical.

Why is Globus Medical stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Globus Medical worth watching?

0 stock analysts on Stockchase covered Globus Medical In the last year. It is a trending stock that is worth watching.

What is Globus Medical stock price?

On 2025-03-14, Globus Medical (GMED-N) stock closed at a price of $71.04.